Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycopeptides | 8 | 2023 | 224 | 2.260 |
Why?
|
| Hyponatremia | 10 | 2022 | 298 | 2.100 |
Why?
|
| Sodium | 8 | 2023 | 1623 | 1.420 |
Why?
|
| Diabetes Insipidus | 4 | 2020 | 151 | 1.090 |
Why?
|
| Nocturnal Enuresis | 1 | 2023 | 12 | 0.910 |
Why?
|
| Polyuria | 3 | 2023 | 39 | 0.890 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2022 | 703 | 0.770 |
Why?
|
| Beer | 1 | 2020 | 127 | 0.710 |
Why?
|
| Water-Electrolyte Balance | 1 | 2020 | 346 | 0.650 |
Why?
|
| Pituitary Gland | 1 | 2021 | 665 | 0.640 |
Why?
|
| Oxytocin | 2 | 2023 | 394 | 0.640 |
Why?
|
| Humidity | 1 | 2019 | 197 | 0.630 |
Why?
|
| Saline Solution, Hypertonic | 3 | 2023 | 110 | 0.580 |
Why?
|
| Seasons | 2 | 2020 | 1493 | 0.560 |
Why?
|
| Arginine | 4 | 2023 | 944 | 0.500 |
Why?
|
| Water | 2 | 2022 | 1395 | 0.490 |
Why?
|
| Hot Temperature | 1 | 2019 | 1354 | 0.440 |
Why?
|
| Arginine Vasopressin | 3 | 2023 | 130 | 0.430 |
Why?
|
| Pressure Ulcer | 2 | 2023 | 155 | 0.390 |
Why?
|
| Inappropriate ADH Syndrome | 2 | 2021 | 61 | 0.370 |
Why?
|
| Immunoglobulin Fc Fragments | 3 | 2022 | 279 | 0.360 |
Why?
|
| Glucagon-Like Peptides | 2 | 2021 | 127 | 0.350 |
Why?
|
| Spinal Cord Injuries | 3 | 2023 | 931 | 0.350 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 12959 | 0.310 |
Why?
|
| Pituitary-Adrenal System | 2 | 2022 | 553 | 0.300 |
Why?
|
| Glucosides | 2 | 2021 | 451 | 0.290 |
Why?
|
| Benzhydryl Compounds | 3 | 2022 | 845 | 0.280 |
Why?
|
| Autonomic Dysreflexia | 1 | 2023 | 9 | 0.230 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2023 | 19 | 0.230 |
Why?
|
| Deficiency Diseases | 1 | 2023 | 72 | 0.230 |
Why?
|
| Hypernatremia | 2 | 2021 | 82 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2022 | 3772 | 0.230 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2022 | 648 | 0.220 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2023 | 91 | 0.220 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2023 | 65 | 0.220 |
Why?
|
| Drinking | 2 | 2021 | 197 | 0.210 |
Why?
|
| Vasopressins | 1 | 2022 | 370 | 0.190 |
Why?
|
| Natriuretic Peptides | 1 | 2021 | 150 | 0.180 |
Why?
|
| Ion-Selective Electrodes | 1 | 2019 | 6 | 0.180 |
Why?
|
| Diabetes Insipidus, Nephrogenic | 1 | 2019 | 23 | 0.170 |
Why?
|
| Tryptophan | 1 | 2021 | 478 | 0.170 |
Why?
|
| Hydrocortisone | 3 | 2022 | 1826 | 0.170 |
Why?
|
| Pneumonia | 2 | 2020 | 2133 | 0.160 |
Why?
|
| Young Adult | 8 | 2023 | 56430 | 0.150 |
Why?
|
| Community-Acquired Infections | 1 | 2020 | 465 | 0.140 |
Why?
|
| Switzerland | 3 | 2021 | 255 | 0.140 |
Why?
|
| Cross-Over Studies | 4 | 2023 | 2029 | 0.130 |
Why?
|
| Hypoglycemic Agents | 4 | 2022 | 2872 | 0.130 |
Why?
|
| Double-Blind Method | 7 | 2023 | 12026 | 0.130 |
Why?
|
| Prospective Studies | 10 | 2023 | 53288 | 0.130 |
Why?
|
| Hospitalization | 5 | 2021 | 10262 | 0.120 |
Why?
|
| Adult | 12 | 2023 | 214055 | 0.120 |
Why?
|
| Male | 18 | 2022 | 350118 | 0.120 |
Why?
|
| Humans | 29 | 2023 | 744343 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 11725 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5751 | 0.110 |
Why?
|
| Indoles | 1 | 2021 | 1839 | 0.110 |
Why?
|
| Writing | 1 | 2015 | 206 | 0.110 |
Why?
|
| Female | 17 | 2022 | 380194 | 0.100 |
Why?
|
| Patients | 1 | 2018 | 900 | 0.100 |
Why?
|
| Anemia | 1 | 2020 | 1506 | 0.090 |
Why?
|
| Recurrence | 2 | 2020 | 8340 | 0.090 |
Why?
|
| Homeostasis | 1 | 2020 | 3340 | 0.080 |
Why?
|
| Inpatients | 1 | 2020 | 2518 | 0.080 |
Why?
|
| Educational Measurement | 1 | 2015 | 1210 | 0.080 |
Why?
|
| Middle Aged | 9 | 2021 | 213383 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2023 | 63114 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 3966 | 0.070 |
Why?
|
| Aged | 9 | 2023 | 163280 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2020 | 3749 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2017 | 3114 | 0.060 |
Why?
|
| Natriuresis | 1 | 2022 | 124 | 0.050 |
Why?
|
| Thirst | 1 | 2021 | 38 | 0.050 |
Why?
|
| Students, Medical | 1 | 2015 | 1862 | 0.050 |
Why?
|
| Inflammation | 1 | 2021 | 10638 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 40561 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25043 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20947 | 0.050 |
Why?
|
| Renin | 1 | 2022 | 642 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 340 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7659 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2015 | 4245 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 21746 | 0.040 |
Why?
|
| Stimulation, Chemical | 1 | 2019 | 326 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2020 | 683 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2022 | 881 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2017 | 6882 | 0.040 |
Why?
|
| Hospitals | 2 | 2023 | 3952 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2020 | 571 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 684 | 0.040 |
Why?
|
| Child | 2 | 2023 | 77709 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57776 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2020 | 3313 | 0.040 |
Why?
|
| Aldosterone | 1 | 2022 | 877 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 72290 | 0.030 |
Why?
|
| Physical Examination | 1 | 2020 | 1237 | 0.030 |
Why?
|
| Triage | 1 | 2021 | 976 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15226 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4933 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2019 | 1951 | 0.020 |
Why?
|
| Saliva | 1 | 2015 | 809 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4397 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29063 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39050 | 0.020 |
Why?
|
| Critical Care | 1 | 2021 | 2647 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77449 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6309 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2624 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2021 | 5317 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6256 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14722 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 12804 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23338 | 0.010 |
Why?
|
| Adolescent | 1 | 2023 | 85781 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_